Elevated cerebrospinal fluid levels of glutamate in children with bacterial meningitis as a predictor of the development of seizures or other adverse outcomes

Pediatric Critical Care Medicine

Volumn 4, Issue 2, 2003, Pages 170-175

  Ma, William ^a   Shang Feaster, Gwendoline ^b   Okada, Pamela J ^a,b   Kernie, Steven G ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

Author keywords

Excitotoxicity; Glutamate; Meningitis; Neurotransmitter; Seizures; Streptococcus pneumoniae

Indexed keywords

GLUTAMIC ACID DERIVATIVE;

ADOLESCENT; ARTICLE; BACTERIAL MENINGITIS; CASE CONTROL STUDY; CEREBROSPINAL FLUID; CHILD; FEMALE; HUMAN; INFANT; MALE; NEWBORN; PREDICTION AND FORECASTING; PRESCHOOL CHILD; PUNCTURE; SEIZURE; STREPTOCOCCUS INFECTION;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GLUTAMATES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, BACTERIAL; PNEUMOCOCCAL INFECTIONS; PREDICTIVE VALUE OF TESTS; SEIZURES; SPINAL PUNCTURE;

EID: 0038824754     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/01.PCC.0000059735.08694.8F     Document Type: Article

References (42)

1. Gasic GP, Hollmann M: Molecular neurobiology of glutamate receptors. Annu Rev Physiol 1992; 54:507-536
2. Nakanishi S: Molecular diversity of glutamate receptors and implications for brain function. Science 1992; 258:597-603
3. Lipton SA, Rosenberg PA: Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994; 330: 613-622
4. Choi DW: Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1:623-634
5. Plaitakis A, Shashidharan P: Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: Implications for the pathogenesis of Parkinson's disease. J Neurol 2000; 247(Suppl 2):II25-II35
6. Ludolph AC, Meyer T, Riepe MW: The role of excitotoxicity in ALS: What is the evidence? J Neurol 2000; 247(Suppl 1):I7-I16
7. Petralia RS, Rubio ME, Wang YX, et al: Differential distribution of glutamate receptors in the cochlear nuclei. Hear Res 2000; 147: 59-69
8. Parks TN: The AMPA receptors of auditory neurons. Hear Res 2000; 147:77-91
9. Minino AM, Smith BL: Deaths: Preliminary data for 2000. National Vital Statistics Report 2001; 49:25. Available online at: www.cdc. gov. Accessed February 21, 2002
10. Alpern ER, Alessandrini EA, Bell LM, et al: Occult bacteremia from a pediatric department: Current prevalence, time to detection, and outcome. Pediatrics 2000; 106:505-511
11. Lee GM, Harper MB: Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era. Arch Pediatr Adolesc Med 1998; 152:624-628
12. Overturf GD: American Academy of Pediatrics: Committee on Infectious Diseases. Technical report: Prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics 2000; 106(2 Pt 1):367-376
13. Finkelstein JA, Christiansen CL, Platt R: Fever in pediatric primary care: Occurrence, management, and outcomes. Pediatrics 2000; 105:260-266
14. Quagliarello VJ, Scheld WM: Treatment of bacterial meningitis. N Engl J Med 1997; 336:708-716
15. Schuchat A, Robinson K, Wenger JD, et al: Bacterial meningitis in the United States in 1995. N Engl J Med 1997; 337:970-976
16. Schuchat A, Hilger T, Zell E, et al: Active bacterial core surveillance of the emerging infections program network. Emerg Infect Dis 2001; 7:92-99
17. Sadow KB, Derr R, Teach SJ: Bacterial infections in infants 60 days and younger. Arch Pediatr Adolesc Med 1999; 153:611-614
18. Rosman NP, Peterson DB, Kaye EM, et al: Seizures in bacterial meningitis: Prevalence, patterns, pathogenesis, and prognosis. Pediatr Neurol 1985; 1:278-285
19. Grimwood K, Anderson VA, Bond L, et al: Adverse outcomes of bacterial meningitis in school-age survivors. Pediatrics 1995; 95: 646-656
20. Grimwood K, Anderson P, Anderson V, et al: Twelve year outcomes following bacterial meningitis: further evidence for persisting effects. Arch Dis Child 2000; 83:111-116
21. Pomeroy SL, Holmes SJ, Dodge PR, et al: Seizures and other neurologic sequelae of bacterial meningitis in children. N Engl J Med 1990; 323:1651-1657
22. Baraff LJ, Lee SI, Schriger DL: Outcomes of bacterial meningitis in children: A metaanalysis. Pediatr Infect Dis J 1993; 12: 389-394
23. Maragakis NJ, Rothstein JD: Glutamate transporters in neurologic disease. Arch Neurol 2001; 58:365-370
24. Spranger M, Schwab S, Krempien S, et al: Excess glutamate levels in the cerebrospinal fluid predict clinical outcome of bacterial meningitis. Arch Neurol 1996; 53:992-996
25. Arditi M, Mason EO Jr, Bradley JS, et al: Three-year multicenter surveillance of pneumococcal meningitis in children: Clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998; 102:1087-1097
26. Kornelisse RF, Westerbeck CML, Spoor AB, et al: Pneumococcal meningitis in children: Prognostic indicators and outcome. Clin Infect Dis 1995; 21:1390-1397
27. Spranger M, Krempien S, Schwab S, et al: Excess glutamate in the cerebrospinal fluid in bacterial meningitis. J Neurol Sci 1996; 143:126-131
28. Irazuzta JE, Olson J, Kiefaber MP, et al: Hypothermia decreases excitatory neurotransmitter release in bacterial meningitis in rabbits. Brain Res 1999; 847:143-148
29. Guerra-Romero L, Tureen JH, Fournier MA, et al: Amino acids in cerebrospinal and brain interstitial fluid in experimental pneumococcal meningitis. Pediatr Res 1993; 33: 510-513
30. Saez-Llorens X, Ramilo O, Mustafa MM, et al: Molecular pathophysiology of bacterial meningitis: Current concepts and therapeutic implications. J Pediatr 1990; 5:671-684
31. Ruppel RA, Kochanek PM, Adelson PD, et al: Excitatory amino acid concentrations in ventricular cerebrospinal fluid after severe traumatic brain injury in infants and children: The role of child abuse. J Pediatr 2001; 138: 18-25
32. Quagliarello VJ, Long WJ, Scheld WM: Morphologic alterations of the blood-brain barrier with experimental meningitis in the rat. J Clin Invest 1986; 77:1085-1095
33. Perry VL, Young RSK, Aquila WJ, et al: Effect of experimental Escherichia coli meningitis on concentrations of excitatory and inhibitory amino acids in the rabbit brain: In vivo microdialysis study. Pediatr Res 1993; 34: 187-191
34. Petito CK, Chung MC, Verkhovsky LM, et al: Brain glutamine synthetase increases following cerebral ischemia in the rat. Brain Res 1992; 569:275-280
35. Tumani H, Smirov A, Barchfeld S, et al: Inhibition of glutamine synthetase in rabbit pneumococcal meningitis is associated with neuronal apoptosis in the dentate gyrus. Glia 2000; 30:11-18
36. Gemba T, Oshima T, Ninomiya M: Glutamate efflux via the reversal of the sodiumdependent glutamate transporter caused by glycolytic inhibition in rat cultured astrocytes. Neuroscience 1994; 63:789-795
37. Donato R: Perspectives in S-100 protein biology. Cell Calcium 1991; 12:713-726
38. Marangos PJ, Zis AP, Clark RL, et al: Neuronal, non-neuronal and hybrid forms of enolase in brain: Structural, immunological and functional comparisons. Brain Res 1978; 150:117-133
39. DeGiorgio CM, Heck CN, Rabinowicz AL, et al: Serum neuronal-specific enolase in the major subtypes of status epilepticus. Neurology 1999; 52:746-749
40. Pleines UE, Morganti-Kossman MC, Rancan M, et al: S-100- reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J Neurotrauma 2001; 18:491-498
41. Schroeder S, Lindemann C, Hoeft A, et al: Impaired inducibility of heat shock protein 70 in peripheral blood lymphocytes of patients with severe sepsis. Crit Care Med 1999; 27:1080-1084
42. Yenari MA, Fink SL, Sun GH, et al: Gene therapy with HSP 72 is neuroprotective in rat models of stroke and epilepsy. Ann Neurol 1998; 44:584-591